FDA Approved: DASATINIB — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved an original application for dasatinib from Zydus Pharmaceuticals USA Inc., enabling a generic version of the cancer drug. Dasatinib is used to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

ORIG AP for DASATINIB (DASATINIB)